Paper39019381
Feasibility, safety, and short-term follow-up of defibrillator lead at left bundle branch area pacing location: A pilot study.
Ponnusamy SS and 2 others. Heart Rhythm, 2024. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Feasibility, safety, and short-term follow-up of defibrillator lead at left bundle branch area pacing location: A pilot study. Papers, record 39019381. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39019381
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Feasibility, safety, and short-term follow-up of defibrillator lead at left bundle branch area pacing location: A pilot study.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Feasibility Studies | Major topic |
| Defibrillators, Implantable | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Pilot Projects | |
| Follow-Up Studies | |
| Aged | |
| Bundle of His | |
| Treatment Outcome | |
| Electrocardiography | |
| Time Factors |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42137497 | Left Bundle Branch Area Pacing with a Defibrillator Lead in a Patient with Recurrent Ventricular Tachycardia and Severe Nonischemic Cardiomyopathy: A Case Report. | J Innov Card Rhythm Manag | 2026 | https://conductscience.org/library/papers/42137497 | PubMed |
| 41319126 | Cost-Utility Analysis of Left Bundle Branch Area Versus Biventricular Pacing for Cardiac Resynchronization Therapy: A Multicenter, Prospective, Quasi-Experimental Study. | J Cardiovasc Electrophysiol | 2026 | https://conductscience.org/library/papers/41319126 | PubMed |
| 41217488 | [ICD electrode implantation for left bundle branch area pacing]. | Herzschrittmacherther Elektrophysiol | 2025 | https://conductscience.org/library/papers/41217488 | PubMed |
| 40762927 | First in-human reverse LOT-CRT defibrillator. | J Interv Card Electrophysiol | 2026 | https://conductscience.org/library/papers/40762927 | PubMed |
| 40726437 | Left bundle branch pacing in patients with structural heart disease: personalizing cardiac resynchronization therapy. | Europace | 2025 | https://conductscience.org/library/papers/40726437 | PubMed |
| 40159278 | European Society of Cardiology (ESC) clinical consensus statement on indications for conduction system pacing, with special contribution of the European Heart Rhythm Association of the ESC and endorsed by the Asia Pacific Heart Rhythm Society, the Canadian Heart Rhythm Society, the Heart Rhythm Society, and the Latin American Heart Rhythm Society. | Europace | 2025 | https://conductscience.org/library/papers/40159278 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39019381
GET https://conductscience.org/api/papers/v1/39019381/authors